Cogent Biosciences Stock 346% Surge Fueled by New Stake
A Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
Which index fund performed best this year? Review top performers, volatility, and potential shifts to inform your next move.
26,831 articlesA Phase 3 breakthrough unleashed a dramatic move in Cogent Biosciences. A large fund followed with a sizable stake, s...
As markets swing in early 2026, three actively-managed ETFs are drawing inflows for steady income and downside protec...
A niche nuclear tech stock reported solid revenue gains, but a large fund reduced its holdings. Learn how to read the...
A bold, income-focused play shows up when a wealth manager made million-for-a-6.4% yield bet on a senior loan ETF. Th...
Global tax debates touch every paycheck. This article breaks down three policy ideas and shows how the tax benefits o...
Jonathan Clements changed how everyday investors think about money. In this MiB-inspired reflection, Jason Zweig and ...
Analysts say Microsoft’s AI push is unlikely to threaten dividend safety inside Vanguard’s Dividend Appreciation ETF ...
As natural gas swings capture traders’ attention, UNG and FCG offer competing paths: near-term futures exposure vs. e...
Imagine starting with a $10,000 Alphabet Right Now investment and letting time compound. This article walks you throu...
ARTY posted a 12-month gain of 28.3%, topping QQQ's 14.3% and SPY's 13.7%, as AI infrastructure exposure draws buyers...
Retirees on $2,500 monthly face very different realities in Mexico and Florida. Housing, insurance, and residency rul...
May data show five straight months of growth for U.S. manufacturers, marking the longest winning streak since 2022. Y...